Sequence information
Variant position: 540 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 605 The length of the canonical sequence.
Location on the sequence:
TFTPQPPGLERLWLEGNPWD
C GCPLKALRDFALQNPSAVPR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TFTPQPPGLERLWLEGNPWDC GCPLKALRDFALQNPSAVPR
Mouse TFVPQP-GLERLWLDANPWDC SCPLKALRDFALQNPGVVPR
Rat TFSPQP-GLERLWLDANPWDC SCPLKALRDFALQNPGVVPR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
28 – 605
Insulin-like growth factor-binding protein complex acid labile subunit
Domain
536 – 605
LRRCT
Literature citations
Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations.
Domene H.M.; Scaglia P.A.; Lteif A.; Mahmud F.H.; Kirmani S.; Frystyk J.; Bedecarras P.; Gutierrez M.; Jasper H.G.;
J. Clin. Endocrinol. Metab. 92:4444-4450(2007)
Cited for: VARIANTS ACLSD SER-LEU-ARG-197 INS AND ARG-540;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.